57933-83-2 Usage
Uses
Used in Pharmaceutical Industry:
Isopropenyl chloroformate is used as a reagent for the preparation of ketones via palladium-catalyzed decarboxylative cross-coupling reaction of benzyl vinyl carbonates. This application is significant in the pharmaceutical industry as it aids in the synthesis of complex organic molecules, which are essential for the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
Isopropenyl chloroformate is also employed in organic synthesis as a versatile reagent for the formation of various chemical bonds and functional groups. Its ability to react with a wide range of substrates makes it a valuable tool in the synthesis of complex organic molecules, including those with potential applications in materials science, agrochemicals, and other industries.
Used in Research and Development:
In the field of research and development, Isopropenyl chloroformate is utilized as a key intermediate in the synthesis of novel compounds with potential applications in various industries. Its unique reactivity and versatility make it an attractive candidate for exploring new reaction pathways and developing innovative synthetic methods.
Synthesis Reference(s)
The Journal of Organic Chemistry, 43, p. 752, 1978 DOI: 10.1021/jo00398a058
Hazard
Strong irritant to eyes and skin.
Check Digit Verification of cas no
The CAS Registry Mumber 57933-83-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,9,3 and 3 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 57933-83:
(7*5)+(6*7)+(5*9)+(4*3)+(3*3)+(2*8)+(1*3)=162
162 % 10 = 2
So 57933-83-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H5ClO2/c1-3(2)7-4(5)6/h1H2,2H3
57933-83-2Relevant academic research and scientific papers
Qunoline intermediates useful therein for synthesizing antibacterial compounds
-
, (2008/06/13)
A novel process and intermediates used therein for linking a cephalosporin compound to a quinolone are disclosed. According to the disclosed process, the 2-carboxylic acid moiety of the cephalosporin compound is treated with an organic base. The resulting salt is then reacted with a quinolone compound which has been activated using a haloformate. The reaction is run in a non-aqueous organic solvent. 4-Dimethylaminopyridine is used to promote the reaction between the cephalosporin salt and the activated quinolone.